Glenmark Pharma

Rediff.com » News » Glenmark Pharma

News for Glenmark Pharma

News
Business

Pharma majors shift focus to inhalants, nasal spray for Covid

While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus......

Why Is USFDA Inspecting India Pharma Firms?

Kindly note the image has been posted only for representational purposes.Photograph: Kind courtesy Pixabay.com The Indian pharmaceutical industry's recent tryst with the US drug regulator......

First nasal spray for treating Covid patients launched in India

Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering......

With Covid surge, FabiFlu becomes most sold drug in India

Drugs that are used to treat Covid or used by people as immunity boosters have seen a jump in sales and, in turn, rankings, reports Sohini Das. IMAGE: A chemist displays the Fabiflu......

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......

Glenmark Pharma, US firm ink pact

In a bid to tap overseas market, Glenmark Pharmaceuticals Ltd's wholly owned US subsidiary has entered into a product development and marketing licence agreement with US-based K V Pharmaceutical......

Pharma stocks slide as US headwinds hurt

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US — their largest export market — have weighed heavily on investor sentiment this year. Photograph: Amit......

Glenmark Pharma buys Brazilian firm

In a bid to tap the potential in Latin America, Glenmark Pharmaceuticals Ltd has acquired Brazil-based Laboratorios Klinger, ranked among the top 50 in that country, for $5.2 million."The Brazilian......

Glenmark Pharma net dips 31 percent

A sharp increase in interest costs has caused Glenmark Pharmaceuticals to post a consolidated net profit of Rs 80.9 crore for the second quarter, 31 percent lower than the Rs 117.3 crore for the......

Glenmark Pharma to divest stake in arm

Glenmark Pharmaceuticals Ltd plans to divest its subsidiary Glenmark Laboratories Ltd to Mark Saldanha and his associates for Rs 350 million. It also plans to sell its manufacturing plant at Verna,......

Glenmark Pharma

News for Glenmark Pharma

Pharma majors shift focus to inhalants, nasal spray for Covid

Why Is USFDA Inspecting India Pharma Firms?

First nasal spray for treating Covid patients launched in India

With Covid surge, FabiFlu becomes most sold drug in India

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Glenmark Pharma, US firm ink pact

Pharma stocks slide as US headwinds hurt

Glenmark Pharma buys Brazilian firm

Glenmark Pharma net dips 31 percent

Glenmark Pharma to divest stake in arm

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS